Ginkgo Bioworks acquires Zymergen for $300M
In Massachusetts, Ginkgo Bioworks and the biotechnology company Zymergen (have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an all-stock transaction that values Zymergen at an approximately $300 million market capitalization. Under the terms of the agreement, which have been unanimously approved by the boards of directors of both companies, Zymergen […]














